Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson's disease genes.
Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson's disease genes.
复制标题
全转录组关联研究与神经元功能障碍测定的整合为帕金森病基因提供了功能基因组学证据。
DOI:
10.1093/hmg/ddac230
复制
发表时间:
2023
影响因子:
3.5
通讯作者:
Botas,Juan
中科院分区:
文献类型:
--
作者:
Li,Jiayang;Amoh,BismarkKojo;McCormick,Emma;Tarkunde,Akash;Zhu,KatyFan;Perez,Alma;Mair,Megan;Moore,Justin;Shulman,JoshuaM;Al-Ramahi,Ismael;Botas,Juan
Genome-wide association studies (GWAS) have markedly advanced our understanding of the genetics of Parkinson’s disease (PD), but they currently do not account for the full heritability of PD. In many cases it is difficult to unambiguously identify a specific gene within eachlocusbecause GWAS does not provide functional information on the identified candidateloci. Here we present an integrative approach that combines transcriptome-wide association study (TWAS) with high-throughput neuronal dysfunction analyses inDrosophilato discover and validate candidate PD genes. We identified 160 candidate genes whose misexpression is associated with PD risk via TWAS. Candidates were validated using orthogonalin silicomethods and found to be functionally related to PD-associated pathways (i.e. endolysosome). We then mimicked these TWAS-predicted transcriptomic alterations in aDrosophilaPD model and discovered that 50 candidates can modulate α-Synuclein(α-Syn)-induced neurodegeneration, allowing us to nominate new genes in previously known PD loci. We also uncovered additional novel PD candidate genes within GWAS suggestiveloci(e.g.TTC19, ADORA2B, LZTS3, NRBP1, HN1L), which are also supported by clinical and functional evidence. These findings deepen our understanding of PD, and support applying our integrative approach to other complex trait disorders.